Literature DB >> 3455068

Dipsogenic diabetes insipidus: a newly recognized syndrome caused by a selective defect in the osmoregulation of thirst.

G L Robertson1.   

Abstract

We describe three patients who have polydipsia and polyuria due to an abnormality in the osmoregulation of thirst. The clinical manifestations of the syndrome are similar to those of neurogenic diabetes insipidus. Thus, under basal conditions the patients have thirst, normal to high normal levels of plasma osmolality, and low levels of plasma vasopressin. Moreover, antidiuretic therapy greatly reduces thirst and polydipsia as well as polyuria. The only clinically distinguishing feature of the response is that thirst and water intake decrease less rapidly than water excretion. As a consequence, the patients with this syndrome develop variable degrees of dilutional hyponatremia and hypoosmolemia during treatment. The plasma vasopressin response to osmotic stimulation is relatively normal. In most of the patients, the osmotic threshold for vasopressin release is at the upper limit of normal, but this finding only explains their modest elevation in basal plasma osmolality. Thirst and water intake also change as a function of plasma osmolality. However, the threshold or "set" of the thirst osmostat appears to be abnormally low. The degree of downward resetting varies from patient to patient, but is always sufficient to stimulate thirst and water intake at levels of plasma osmolality below the normal range. This abnormality can account not only for the thirst and polyuria under basal conditions but also for the overhydration that occurs during antidiuretic therapy. The pathogenesis of the osmoregulatory abnormality is unknown but may be due to disruption of one or more of the afferent pathways that regulate the "set" of the thirst and vasopressin osmostats.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3455068

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN: 0066-9458


  8 in total

Review 1.  Diabetes insipidus.

Authors:  Joseph G Verbalis
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Dipsogenic potentiation by sodium chloride but not by sucrose or polyethylene glycol in tuberomammillary-mediated polydipsia.

Authors:  J Mahía; A Bernal; A Puerto
Journal:  Exp Brain Res       Date:  2007-07-14       Impact factor: 1.972

Review 3.  Familial forms of diabetes insipidus: clinical and molecular characteristics.

Authors:  Muriel Babey; Peter Kopp; Gary L Robertson
Journal:  Nat Rev Endocrinol       Date:  2011-07-05       Impact factor: 43.330

Review 4.  Management of disorders of water metabolism in patients with pituitary tumors.

Authors:  Joseph G Verbalis
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 5.  Primary polydipsia: Update.

Authors:  Leeda Ahmadi; Morris B Goldman
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-10-14       Impact factor: 4.690

6.  Dipsogenic diabetes insipidus: report of a novel treatment strategy and literature review.

Authors:  Robert M Perkins; Christina M Yuan; Paul G Welch
Journal:  Clin Exp Nephrol       Date:  2006-03       Impact factor: 2.801

7.  Probable primary polydipsia in a domestic shorthair cat.

Authors:  Charles Tyler Long; Morika Williams; Mason Savage; Jonathan Fogle; Rick Meeker; Lola Hudson
Journal:  JFMS Open Rep       Date:  2015-12-01

8.  Approach to the Patient: "Utility of the Copeptin Assay".

Authors:  Mirjam Christ-Crain; Julie Refardt; Bettina Winzeler
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.